A woman in Santos, São Paulo, faces indictment by Civil Police for the clandestine trade of tirzepatide, commonly known as Mounjaro. This indictment occurred on the 11th of last week, following an operation that began in December 2025, aimed at uncovering illegal activities related to the supply of this medication. The investigation was triggered by complaints, leading officers from the 2nd Police District to the suspect and two healthcare professionals at a hospital in the Campo Grande neighborhood.

During the operation, authorities executed search and seizure warrants issued by the 7th Judicial Administrative Region in Santos at the homes of the accused and the hospital. Officers were able to confiscate vials of tirzepatide allegedly being sold illegally by the two health professionals. However, there was no information provided on whether those implicated in the scandal have been suspended from their duties, raising concerns about the oversight of medical practices in the area.

This situation highlights the ongoing issues with drug regulation enforcement and the potential risks associated with the illegal trade of medication, especially in a hospital environment where patient safety could be at stake. The case not only sheds light on the individuals involved but also calls for further scrutiny into the healthcare practices in Brazil, particularly in terms of accountability and adherence to legal protocols regarding prescription medications.